Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Total Liabilities: 2016-2025

Historic Total Liabilities for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $123.8 million.

  • Organogenesis Holdings' Total Liabilities fell 26.17% to $123.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.8 million, marking a year-over-year decrease of 26.17%. This contributed to the annual value of $112.6 million for FY2024, which is 37.93% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Total Liabilities of $123.8 million as of Q3 2025, which was up 23.96% from $99.9 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Total Liabilities peaked at $202.0 million during Q2 2022, and registered a low of $99.3 million during Q1 2025.
  • For the 3-year period, Organogenesis Holdings' Total Liabilities averaged around $153.8 million, with its median value being $179.0 million (2023).
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 36.06% in 2021, then plummeted by 44.96% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Total Liabilities (Quarterly) stood at $201.9 million in 2021, then dropped by 9.03% to $183.7 million in 2022, then declined by 1.27% to $181.4 million in 2023, then tumbled by 37.93% to $112.6 million in 2024, then decreased by 26.17% to $123.8 million in 2025.
  • Its last three reported values are $123.8 million in Q3 2025, $99.9 million for Q2 2025, and $99.3 million during Q1 2025.